✦ LIBER ✦

Phase I/II trial of docetaxel and concurrent radiation therapy in localized high risk prostate cancer (AGUSG 03-10)

✍ Scribed by Michael Perrotti; Todd Doyle; Parvesh Kumar; Daryl McLeod; William Badger; Susan Prater; Michael Moran; Stuart Rosenberg; Cora Bonatsos; Carrie Kreitner; Ralf Kiehl; Theodore Chang; Michael Kolodziej

Book ID: 116956127
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 91 KB
Volume: 26
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2007.04.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of concurrent weekly docet

Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer

✍ Ronald C. Chen; Julian G. Rosenman; Leroy G. Hoffman; Wing-Keung Chiu; Andrew Z. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

Phase I/II Study of Preoperative Radiati

Phase I/II Study of Preoperative Radiation and Docetaxel Activity Study for High-Risk Prostate Cancer

✍ A.Y. Hung; P.E. Farris; T. Beer; M. Garzotto 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Concurrent and adjuvant docetaxel with t

Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: Preliminary results of a multicentre phase II trial

✍ Michel Bolla; Jean Michel Hannoun-Levi; Jean-Marc Ferrero; Philippe Maingon; Joë 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Phase I/II study of docetaxel and cispla

Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer

✍ Kiura, K; Ueoka, H; Segawa, Y; Tabata, M; Kamei, H; Takigawa, N; Hiraki, S; Wata 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

Phase II trial of neoadjuvant docetaxel

Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer

✍ Jacqueline Vuky; Christopher Porter; Christina Isacson; Matthew Vaughan; Paul Ko 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract ## BACKGROUND: Prostate cancer trials investigating neoadjuvant hormonal therapy, followed by surgery, have demonstrated that elimination of all tumor cells from the primary site is rare. The authors report a phase 2 trial assessing the efficacy and toxicity of docetaxel and gefitinib

Phase 2 study of neoadjuvant docetaxel p

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer : A Prostate Cancer Clinical Trials Consortium trial

✍ Robert W. Ross; Matthew D. Galsky; Phil Febbo; Marc Barry; Jerome P. Richie; Wan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB